1. Han Q, Lin Q, Jin S, You L. Recent insights into 2019-nCoV: a brief but comprehensive review. J Infect. 2020. https://doi.org/10.1016/j.jinf.2020.02.010(Epub ahead to print).
2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.
3. WHO Coronavirus Disease 2019 (COVID-19) Situation Report-52. https://www.who.int/docs/default-source/coronaviruse/20200312-sitrep-52-covid-19.pdf?sfvrsn=e2bfc9c0_2. Accessed 12 Mar 2020.
4. Liu S, He G, Du J, Wang D, Shi C, Huang Q, et al. Pharmaceutical emergency guarantee difficulties and countermeasures for the prevention and control of outbreak of novel coronavirus pneumonia (NCP). Chin J Hosp Pharm. 2020;40(3):243–9.
5. The Chinese Pharmaceutical Association. The coronavirus SARS-CoV-2 infection: expert consensus on hospital pharmaceutical work guidance and prevention and control strategies. https://www.cpa.org.cn/cpadmn/attached/file/20200216/1581852960473177.pdf. Accessed 12 Mar 2020.